Profile
Peter Damsbo is currently the Chief Medical Officer at Coegin Pharma.
AS since 2010 and a Partner at Ventac Partners GmbH since 2009.
He previously worked as the Medical Director-Diabetes at Novo Nordisk A from 2011 to 2012, and at Novo Nordisk, Inc. as a Medical Director-Diabetes.
He also served as the Chief Medical Officer at Zealand Pharma A and as a Research Fellow at Steno Diabetes Center A. Dr. Damsbo holds a doctorate degree from the University of Copenhagen.
Peter Damsbo active positions
| Companies | Position | Start |
|---|---|---|
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Develops inflammatory diseases therapeutics | Chief Tech/Sci/R&D Officer | 2010-04-05 |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Corporate Officer/Principal | 2009-05-31 |
Former positions of Peter Damsbo
| Companies | Position | End |
|---|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
Training of Peter Damsbo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Develops inflammatory diseases therapeutics | Health Technology |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Commercial Services |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Commercial Services |
- Stock Market
- Insiders
- Peter Damsbo
















